BIOQUÍMICA Y BIOLOGÍA MOLECULAR III E INMUNOLOGÍA

2016

1. A historical overview of protein kinase PKR: from its discovery and mechanism of action to its clinical and therapeutic implications

   Anales de la Real Academia Nacional de Farmacia, Vol. 82, Núm. 2, pp. 143-167

2. A new pharmacogenetic algorithm to predict the most appropriate dosage of acenocoumarol for stable anticoagulation in a mixed Spanish population

   PLoS ONE, Vol. 11, Núm. 3

3. Absence of WASp enhances hematopoietic and megakaryocytic differentiation in a human embryonic stem cell model

   Molecular Therapy, Vol. 24, Núm. 2, pp. 342-353

4. Analysis of microrna microarrays in cardiogenesis

   Methods in Molecular Biology, Vol. 1375, pp. 207-221

5. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk

   Urologic Oncology: Seminars and Original Investigations, Vol. 34, Núm. 10, pp. 431.e1-431.e8

6. Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population

   Prostate Cancer and Prostatic Diseases, Vol. 19, Núm. 1, pp. 28-34

7. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: The influence of human leucocyte antigen alleles

   Pharmacogenetics and Genomics, Vol. 26, Núm. 9, pp. 414-422

8. Biased and unbiased methods for the detection of off-target cleavage by CRISPR/Cas9: An overview

   International Journal of Molecular Sciences, Vol. 17, Núm. 9

9. Characterisation of genetic structure of the Mayan population in Guatemala by autosomal STR analysis

   Annals of Human Biology, Vol. 43, Núm. 5, pp. 457-468

10. Cholesterol loading in vivo and in vitro alters extracellular matrix proteins production in smooth muscle cells

    European Journal of Lipid Science and Technology, Vol. 118, Núm. 9, pp. 1317-1325

11. Current status of immunotherapy treatments for pancreatic cancer

    Journal of Clinical Gastroenterology, Vol. 50, Núm. 10, pp. 836-848

12. Dormant circulating tumor cells in prostate cancer: Therapeutic, clinical and biological implications

    Current Drug Targets, Vol. 17, Núm. 6, pp. 693-701

13. Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients

    American Journal of Hematology, Vol. 91, Núm. 7, pp. 700-704

14. Effect of HMG-CoA reductase inhibition on vascular smooth muscle cells extracellular matrix production: Role of RhoA

    Current Vascular Pharmacology, Vol. 14, Núm. 4, pp. 345-352

15. Engineering ancestral protein hyperstability

    Biochemical Journal, Vol. 473, Núm. 20, pp. 3611-3620

16. Epistatic interaction between TLR4 and NOD2 in patients with Crohn's Disease: Relation with risk and phenotype in a Spanish cohort

    Immunobiology, Vol. 221, Núm. 9, pp. 927-933

17. Extracción de la cafeína con CO2 supercrítico

    MoleQla: revista de Ciencias de la Universidad Pablo de Olavide, Núm. 21

18. Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

    Cancer Immunology, Immunotherapy, Vol. 65, Núm. 1, pp. 47-59

19. Gene therapy corrects mitochondrial dysfunction in hematopoietic progenitor cells and fibroblasts from Coq9R239X mice

    PLoS ONE, Vol. 11, Núm. 6

20. Generation of MHC class i diversity in primary tumors and selection of the malignant phenotype

    International Journal of Cancer, Vol. 138, Núm. 2, pp. 271-280